Methods and materials for prolonging useful storage of red blood cell preparations and platelet preparations

US9315775B2 · US · B2

Patent metadata
FieldValue
Publication numberUS-9315775-B2
Application numberUS-201414307698-A
CountryUS
Kind codeB2
Filing dateJun 18, 2014
Priority dateMar 16, 2011
Publication dateApr 19, 2016
Grant dateApr 19, 2016

How to read this patent

A practical reading order for non-experts. Skip the full description unless you need deep technical detail.

  1. Title

    What the patent document calls the invention.

  2. Abstract

    A short plain-language summary of the technical disclosure.

  3. Assignees and inventors

    Who owns or filed the patent and who is credited as inventor.

  4. Key dates

    Filing, priority, publication, and grant dates set the timeline.

  5. First independent claim

    The legal scope of protection — read this for what is actually claimed.

  6. CPC / IPC classifications

    Technology tags used to group this patent with similar filings.

  7. Citations and related patents

    Prior art links and similar publications in this corpus.

Abstract

Official abstract text for this publication.

This document provides methods and materials for enhancing the storage capabilities of red blood cell preparations. For example, methods and materials for using CO 2 to store red blood cells in a manner that (a) reduces the level of glucose or 2,3-DPG consumption of or reduces the level of 2,3-DPG production by a red blood cell preparation, (b) reduces the level of lactate formation by a red blood cell preparation, and/or (c) reduces the pH level of a red blood cell preparation are provided. Such methods and materials can result in prolonging the useful lifespan of the red blood cells of the red blood cell preparation. This document also provides methods and materials involved in prolonging useful storage of platelet preparations. For example, methods and materials for storing platelets in a manner that reduces platelet metabolism, that preserves platelet function, and/or that reduces the risk of bacterial contamination are provided.

First claim

Opening claim text (preview).

What is claimed is: 1. A method for treating a platelet concentrate, the method comprising: exposing a platelet concentrate to CO 2 gas under conditions wherein the pCO 2 level of said platelet concentrate is about 150 mmHg of pCO 2 to about 600 mmHg of pCO 2 . 2. The method of claim 1 , wherein said method comprises exposing said platelet concentrate to CO 2 gas under conditions wherein the pCO 2 level of said platelet concentrate is about 200 to about…

Assignees

Inventors

Classifications

  • Human Necessities · mapped topic

  • A01N1/126Primary

    Human Necessities · mapped topic

  • A01N1/10Primary

    Human Necessities · mapped topic

  • Human Necessities · mapped topic

  • C12N5/0644Primary

    Chemistry & Metallurgy · mapped topic

Patent family

Related publications grouped by family.

External sources

Next steps

Free tools are coming soon. Tell us what you want to track and we'll notify you.

Frequently asked questions

Answers are generated from the same data shown on this page.

What does patent US9315775B2 cover?
This document provides methods and materials for enhancing the storage capabilities of red blood cell preparations. For example, methods and materials for using CO 2 to store red blood cells in a manner that (a) reduces the level of glucose or 2,3-DPG consumption of or reduces the level of 2,3-DPG production by a red blood cell preparation, (b) reduces the level of lactate formation by a red b…
Who is the assignee on this patent?
Mayo Foundation, Dynasil Biomedical Corp
What technology area does this patent fall under?
Primary CPC classification A01N1/126. Mapped technology areas include Human Necessities.
When was this patent published?
Publication date Tue Apr 19 2016 00:00:00 GMT+0000 (Coordinated Universal Time) (B2). Legal status and post-grant events are not shown on this page.
What related patents are in patentsdb?
We list 8 related publications on this page (citations in our corpus or others sharing the same primary CPC).